Syntaxin 17 inhibitors belong to a distinct chemical class that plays a crucial role in regulating intracellular membrane fusion events within eukaryotic cells. Syntaxin 17, a member of the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) protein family, is primarily involved in mediating autophagosome-lysosome fusion, a vital process in cellular homeostasis. The inhibition of Syntaxin 17 by specific small molecules within this chemical class disrupts the fusion machinery, thereby impeding autophagy, a fundamental cellular process responsible for the degradation and recycling of cellular components. This class of inhibitors is designed to target the unique structural features of Syntaxin 17, preventing its interaction with other SNARE proteins and hindering the formation of the SNARE complex essential for membrane fusion events in autophagy.
Syntaxin 17 inhibitors often possess a combination of hydrophobic and polar functional groups that allow them to interact with specific residues on the Syntaxin 17 protein. These inhibitors may act by binding to the SNARE motif or other critical domains of Syntaxin 17, disrupting its conformation and impeding its ability to participate in the intricate fusion events required for autophagy. The development of Syntaxin 17 inhibitors represents a significant advancement in our understanding of intracellular membrane dynamics and provides valuable tools for researchers to dissect the molecular mechanisms underlying autophagic processes. As researchers continue to explore the intricate details of autophagy and the role of Syntaxin 17, the study and refinement of these inhibitors contribute to the growing body of knowledge surrounding cellular physiology
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A phosphoinositide 3-kinase (PI3K) inhibitor that can disrupt signaling pathways involved in autophagy, potentially affecting Syntaxin 17 activity. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
Another PI3K inhibitor, known to impede autophagosome formation, which could indirectly affect Syntaxin 17. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $168.00 | ||
An autophagy inhibitor that promotes the degradation of autophagy-related proteins, potentially altering the function of Syntaxin 17. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
A known autophagy inhibitor that raises lysosomal pH, which may influence the fusion process mediated by Syntaxin 17. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
A vacuolar-type H+-ATPase inhibitor that prevents acidification of lysosomes and autophagosome fusion, potentially impacting Syntaxin 17. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
Similar to Bafilomycin A1, this compound inhibits the acidification of lysosomes, affecting the fusion process involving Syntaxin 17. | ||||||
SAR405 | 1523406-39-4 | sc-507416 | 1 mg | $125.00 | ||
A specific inhibitor of the Vps34 PIK3C3 complex that can disrupt autophagy, possibly altering Syntaxin 17's role. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A broad-spectrum PI3K inhibitor that can affect multiple signaling pathways, including those related to autophagy, potentially influencing Syntaxin 17. | ||||||
MHY1485 | 326914-06-1 | sc-507522 | 10 mg | $140.00 | ||
An mTOR activator that can inhibit autophagy by preventing the activation of downstream targets, indirectly affecting Syntaxin 17. | ||||||
FCM Lysing solution (1x) | sc-3621 | 150 ml | $62.00 | 8 | ||
Raises lysosomal pH like Chloroquine, which could affect the function of Syntaxin 17. | ||||||